SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019718
Filing Date
2023-12-11
Accepted
2023-12-11 16:30:27
Documents
14
Period of Report
2023-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20231210x8k.htm   iXBRL 8-K 58535
2 EX-99.1 mxct-20231210xex99d1.htm EX-99.1 24859
3 GRAPHIC mxct-20231210xex99d1001.jpg GRAPHIC 7633
  Complete submission text file 0001558370-23-019718.txt   227138

Data Files

Seq Description Document Type Size
4 EX-101.SCH mxct-20231210.xsd EX-101.SCH 3131
5 EX-101.LAB mxct-20231210_lab.xml EX-101.LAB 15919
6 EX-101.PRE mxct-20231210_pre.xml EX-101.PRE 10321
8 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20231210x8k_htm.xml XML 4888
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 231478533
SIC: 8731 Services-Commercial Physical & Biological Research